0
0

Cart (0)

Home > Categories > Trilaciclib

Trilaciclib

Sort by
Wishlist

Trilaciclib Impurity-5

  • CAT NUMBER DCTI-C-3431
  • CAS NUMBER 2170746-99-1
  • MOLECULAR FORMULA C20H26N4O3S
  • MOLECULAR WEIGHT 402.51
Wishlist
Wishlist

Trilaciclib Impurity-6

  • CAT NUMBER DCTI-C-3432
  • CAS NUMBER 2170747-00-7
  • MOLECULAR FORMULA C15H18N4OS
  • MOLECULAR WEIGHT 302.4
Wishlist
Wishlist

Trilaciclib Impurity-7

  • CAT NUMBER DCTI-C-3433
  • CAS NUMBER NA
  • MOLECULAR FORMULA C19H24N4O3
  • MOLECULAR WEIGHT 356.43
Wishlist
LOAD MORE
You're viewed all 12 products
References
FAQ's

References

  1. G1 therapeutics information (https://www.g1therapeutics.com/pipeline/trilaciclib/)
  2. Sharpless, Norman E.; Strum, Jay Copeland; Bisi, John Emerson; Roberts, Patrick Joseph; Tavares, Francis Xavier, Highly active anti-neoplastic and anti-proliferative agents, WO2014144740A2, Sep 18, 2014, G1 Therapeutics, Inc., United States (https://patents.google.com/patent/WO2014144740A2/en)

Frequently Asked Questions

Synthetic processes, contamination, degradation, and storage conditions cause Trilaciclib Impurities formation.

Trilaciclib Impurities are critical in drug development to determine drug safety and efficacy.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart